Related by context. All words. (Click for frequent words.) 71 dose atorvastatin 70 hsCRP levels 68 lipid lowering therapy 66 β blockers 66 statin therapy 65 neutrophil counts 65 NSTE ACS 65 platelet reactivity 65 HbA 1c levels 65 dose clopidogrel 65 dose Iluvien 65 hemoglobin A1c levels 65 CVD mortality 64 antihypertensive therapy 64 intensive statin therapy 64 Subgroup analyzes 64 homocysteine concentrations 64 nondiabetic patients 64 bezafibrate 64 serum urate levels 64 density lipoprotein HDL cholesterol 64 periprocedural 64 antithrombotic therapy 64 tirofiban 64 PASI scores 64 umol L 63 noncardiovascular mortality 63 triacylglycerol concentrations 63 serum creatinine levels 63 A1c levels 63 grade gliomas 63 IOP lowering 63 CYPHER Stent 63 elevated CRP 63 postoperative mortality 63 chlorthalidone 63 serum phosphate 63 platelet inhibition 63 colorectal liver metastases 63 polyp recurrence 63 symptomatic VTE 63 colorectal neoplasia 63 NATRECOR R 63 patients undergoing CABG 63 beta blocker therapy 63 TMP SMX 63 dyslipidaemia 62 preoperative chemotherapy 62 LDL lowering 62 LV dysfunction 62 serum lipid levels 62 carotid stenosis 62 NATRECOR ® 62 HbA1C levels 62 definite stent thrombosis 62 doxorubicin docetaxel 62 relapsed MM 62 Doxil ® 62 oncologic outcomes 62 elevated triglyceride levels 62 dose colchicine 62 glycemia 62 simvastatin ezetimibe 62 binary restenosis 62 glomerular filtration 62 dose cytarabine 62 serum vitamin D 62 certolizumab 62 nonfasting triglyceride levels 62 aspirin clopidogrel 62 paclitaxel eluting stents 62 periprocedural MI 62 LDL cholesterol lowering 62 dose ritonavir 62 perioperatively 62 thromboembolic complications 62 nonvertebral fractures 62 Lipitor #mg 62 salmeterol fluticasone 62 aldosterone antagonist 62 myopathy rhabdomyolysis 61 serum phosphate levels 61 arterial thromboembolic events 61 deferiprone 61 serum clusterin levels 61 NNT = 61 paricalcitol 61 intravesical therapy 61 lipid lowering drugs 61 serum LDL cholesterol 61 perioperative mortality 61 atherosclerotic renal artery stenosis 61 serum cortisol 61 nonpharmacologic 61 elevated LDL cholesterol 61 artery stenosis 61 thiazide diuretics 61 Hb A1C 61 CLBP 61 serum urate 61 aldosterone antagonists 61 EDSS scores 61 HIV HCV coinfected 61 endarterectomy 61 Combination therapy 61 serum calcium 61 revascularization procedures 61 #.#/#.# mmHg [001] 61 nicardipine 61 coinfected patients 61 metformin monotherapy 61 fasting triglyceride levels 61 rosuvastatin #mg 61 elevated ALT 61 serum calcium levels 61 baseline HbA1c 61 atherothrombotic events 61 sirolimus eluting stents 61 carotid IMT 61 ARB telmisartan 61 adenoma recurrence 61 fosamprenavir 61 virological failure 61 intracranial stenosis 61 everolimus eluting stents 61 APTIVUS r 61 postoperative chemotherapy 61 prospective observational studies 61 TZDs 61 glycated hemoglobin levels 60 NPH insulin 60 glycosylated hemoglobin HbA1c 60 steroid dexamethasone 60 severe exacerbations 60 teriflunomide 60 extrapyramidal symptoms 60 HbA 1c 60 serum concentrations 60 ruboxistaurin 60 oral prednisolone 60 unfractionated heparin UFH 60 BENICAR HCT 60 IFN beta 60 intensive lipid lowering 60 lipid lowering agents 60 atherogenic dyslipidemia 60 APTIVUS 60 poor metabolizers 60 microvascular complications 60 sUA 60 neurodevelopmental impairment 60 angiographic outcomes 60 triglyceride concentrations 60 subgroup analyzes 60 warfarin therapy 60 statin monotherapy 60 elevated LDH 60 recurrent VTE 60 plasma homocysteine 60 atorvastatin #mg 60 maximally tolerated lipid lowering 60 revascularizations 60 insulin detemir 60 antioxidant supplementation 60 FOSRENOL ® 60 triglyceride concentration 60 loop diuretics 60 AST ALT 60 liver transplant recipients 60 comorbid illnesses 60 glucose lowering 60 dose dexamethasone 60 glycated hemoglobin HbA1c 60 serum triglycerides 60 transferrin saturation 60 VADT 60 antiarrhythmic drug 60 nephron sparing surgery 60 dose cyclophosphamide 60 serum uric acid 60 fluvastatin 60 cardiac toxicity 60 transaminase levels 60 antihypertensive medications 60 perioperative morbidity 60 elevated troponin 60 CYP#D# inhibitor 60 symptomatic intracranial 60 plasma triglycerides 60 oral Hycamtin 60 dosing frequency 60 thromboprophylaxis 60 CsA 60 interferon alfa 2b 60 Pharmacokinetic parameters 60 unfractionated heparin 60 methotrexate monotherapy 60 subclinical hypothyroidism 60 CPAP adherence 60 iPTH 60 IV bisphosphonates 60 nonfasting triglycerides 60 abacavir lamivudine 60 colorectal adenoma 60 HbA1c levels 60 urate levels 59 stone formers 59 tHcy 59 Stent thrombosis 59 moderate renal impairment 59 cirrhotic patients 59 cinacalcet 59 sustained virological response 59 fat vegan diet 59 tipranavir r 59 elevated serum creatinine 59 carotid endarterectomy CEA 59 ACUITY trial 59 recurrent venous thromboembolism 59 androgen suppression 59 dose ionizing radiation 59 tapentadol IR 59 ATACAND 59 PSADT 59 advanced adenomas 59 grade cervical intraepithelial 59 virological response 59 non selective NSAIDs 59 intravenous bisphosphonates 59 lipid lowering medications 59 lumbar spine BMD 59 ELBW infants 59 CLA supplementation 59 pharmacologic therapy 59 conventional antipsychotics 59 plasma glucose levels 59 riociguat 59 beta blocker atenolol 59 ACEIs 59 nonvertebral fracture 59 cranial irradiation 59 symptomatic carotid stenosis 59 Non inferiority 59 HbA1C 59 nonadherence 59 hemoglobin A1c HbA1c 59 oral diclofenac 59 #mg/dL [001] 59 troponins 59 newer atypical antipsychotics 59 seroprotection 59 hematologic toxicity 59 ritonavir boosted lopinavir 59 baseline serum creatinine 59 Flu Cy 59 pharmacokinetic interactions 59 PSA nadir 59 maximal doses 59 follicular lymphoma FL 59 thromboembolic 59 hs CRP 59 sotalol 59 testosterone supplementation 59 locoregional recurrence 59 virologic responses 59 urate lowering 59 obstructive CAD 59 myocardial infarctions MIs 59 fasting glucose levels 59 divalproex sodium 59 hematopoietic cancers 59 intracranial hemorrhage ICH 59 ALT elevation 59 benazepril 59 noncardiac 59 magnesium intake 59 prednisone prednisolone 59 hemoglobin concentrations 59 hepatocellular carcinomas 59 ACCORD Lipid 59 fructose diet 59 Fibrates 59 beta blockers ACE inhibitors 59 DAS# scores 59 RSV hospitalizations 59 troponin T 59 anemia hemoglobin 59 adiponectin levels 59 unstable angina pectoris 59 nonrandomized 59 femoral neck BMD 59 carotid artery stenting 59 placebo dexamethasone 59 HBeAg seroconversion 59 ARCOXIA 58 antiretroviral naïve 58 KIF6 carriers 58 HoFH 58 complete cytogenetic response 58 antihypertensive drugs 58 HER2 expression 58 nephrotoxicity 58 chemoradiotherapy 58 haemorrhagic stroke 58 elevated hsCRP 58 beta carotene supplementation 58 reinfarction 58 serum folate 58 thromboembolic events 58 serum triglyceride levels 58 venlafaxine XR 58 TNF antagonist 58 oral anticoagulation 58 glycosylated hemoglobin levels 58 Cypher Stent 58 intima media thickness 58 fluticasone salmeterol 58 severe hypoglycaemia 58 density lipoprotein cholesterol 58 serum phosphorous 58 PREZISTA r 58 antipsychotic prescribing 58 Drug eluting stent 58 angiotensin converting enzyme inhibitors 58 solifenacin 58 cTnT levels 58 inhaled glucocorticoids 58 PLX STROKE targeting 58 ximelagatran 58 interferon ribavirin 58 Radical prostatectomy 58 baseline LDH 58 blood glucose concentrations 58 ALA PDT 58 daunorubicin 58 radiochemotherapy 58 serum retinol 58 XIENCE V demonstrated 58 preintervention 58 dietary modification 58 ICD therapy 58 Nilotinib 58 tibolone 58 hydroxyvitamin D levels 58 adjuvant radiation 58 reduce serum phosphate 58 Calcium intake 58 nonoperative 58 monoinfected patients 58 antithrombotic therapies 58 ertapenem 58 A1Cs 58 ß blockers 58 nonadherent 58 dalteparin 58 transaminase elevations 58 antiangiogenic therapy 58 grade glioma 58 liver histology 58 albumin excretion 58 NIHSS score 58 antitumor effect 58 antidiabetic drugs 58 repeat revascularization 58 intracerebral haemorrhage 58 DES implantation 58 vertebral fracture 58 conventional angiography 58 alemtuzumab treated 58 antihypertensive agents 58 CP CPPS 58 SORT OUT III 58 adjuvant radiotherapy 58 thoracoscopic lobectomy 58 advanced adenoma 58 dose proportionality 58 viral kinetics 58 morphometric vertebral fractures 58 azilsartan medoxomil 58 concomitant medications 58 selenium supplementation 58 placebo controlled studies 58 clinically meaningful reductions 58 postoperative complication 58 multivessel disease 58 polytherapy 58 fondaparinux 58 upper gastrointestinal bleeding 58 euthyroid 58 hypercholesterolaemia 58 echocardiographic parameters 58 venlafaxine Effexor 58 genotypic resistance 58 nonpharmacologic interventions 58 coronary stenosis 58 mg BID dose 58 coronary calcification 58 thrombotic complications 58 elevated triglycerides 58 Toxicities 58 Baseline characteristics 58 rimonabant #mg 58 plasma renin activity 58 trials RCTs 58 neurologic outcomes 58 inhaled nitric oxide 58 mg/m2 dose 58 MMSE scores 58 p = #.# [003] 58 biochemical recurrence 58 systolic hypertension 58 stavudine d4T 58 locoregional disease 58 recurrent UTI 58 surgical debulking 58 selenium intake 58 prospectively stratified 58 Adjuvant chemotherapy 58 efavirenz EFV 58 thiopurine 58 hydroxyvitamin D concentrations 58 rtPA 58 doxorubicin cyclophosphamide 58 lipid lowering therapies 58 cardiovascular morbidity 58 normotensive 58 PRADAXA #mg 58 Epanova 58 #mmHg [001] 58 pulmonary dysfunction 58 #OHD levels 58 FOLPI 58 Hematologic toxicity 58 antiplatelet drugs 58 clinically meaningful efficacy 58 hsCRP 58 lipid lowering medication 58 rosuvastatin Crestor 58 serum estradiol 58 NNRTI resistance 58 COPD exacerbation 57 GP IIb IIIa inhibitors 57 intact parathyroid hormone 57 thromboembolism 57 pulmonary exacerbations 57 inflammatory biomarkers 57 neurodevelopmental outcomes 57 XIENCE V PROMUS Stent 57 pharmacokinetic interaction 57 antiplatelet therapies 57 dose cohort 57 serum PTH 57 mm Hg diastolic 57 albumin excretion rate 57 dietary calcium intake 57 postoperative AF 57 adalimumab 57 TMC# r 57 carotid plaque 57 stratifying patients 57 lymphocyte counts 57 Ramipril 57 dietary folate intake 57 Zemplar Capsules 57 calcium intakes 57 CIMZIA ™ 57 asymptomatic carotid stenosis 57 Subgroup analysis 57 multivariable adjusted 57 antiangiogenic agents 57 prolactin levels 57 smoldering multiple myeloma 57 nondiabetics 57 aminotransferases 57 pegylated IFN 57 nocturnal hypoglycaemia 57 chronic periodontitis 57 renal tumors 57 fibrinolytic therapy 57 Pioglitazone 57 hypertensives 57 CaPre TM 57 CrCl 57 grade cervical dysplasia 57 CR nPR 57 CIN3 57 transaminases 57 tolterodine ER 57 gemifloxacin 57 alanine aminotransferase ALT 57 Triglyceride levels 57 B7 H3 57 perioperative complications 57 proliferative diabetic retinopathy 57 statistical significance p 57 imipenem 57 melphalan prednisone 57 parkinsonian symptoms 57 arterial thickening 57 anticoagulation 57 iodixanol 57 antiplatelet medications 57 silent ischemia 57 HMG CoA reductase inhibitors 57 plasma homocysteine levels 57 ACE inhibitor ramipril 57 methotrexate therapy 57 pharmacologic treatments 57 dose pravastatin 57 oxycodone CR 57 PRADAXA 57 radiotherapy RT 57 postoperative morbidity 57 ischemic cardiomyopathy 57 paliperidone ER 57 bioavailable testosterone 57 olmesartan 57 LAGB 57 idraparinux 57 antimicrobial prophylaxis 57 nonnucleoside reverse transcriptase inhibitors 57 abciximab 57 contrast induced nephropathy 57 glycemic diet 57 thrombocytopenic 57 pegylated liposomal doxorubicin 57 Platinol ® cisplatin 57 radical nephrectomy 57 cytoreductive surgery 57 systemic toxicity 57 LDL cholesterol levels 57 curative resection 57 antithrombotic 57 5-FU/LV 57 antiandrogens 57 elevated homocysteine 57 PegIFN RBV 57 pravastatin Pravachol 57 pCR 57 multivariable adjustment 57 β blocker 57 clomipramine 57 randomized controlled trials RCTs 57 Ceplene/IL-2 57 serum PSA 57 warfarin anticoagulation 57 residual platelet reactivity 57 systolic dysfunction 57 dosage regimens 57 immunosuppressive regimen 57 anticlotting drugs 57 carotid surgery 57 pamidronate 57 pretest probability 57 biologic DMARD 57 antidiabetic medication 57 acute gout flares 57 ddI 57 dose melphalan 57 caspofungin 57 Retreatment 57 atherosclerotic vascular disease 57 AA Amyloidosis 57 Elitek 57 severe periodontitis 57 angiographically 57 mL/min/#.# m 2 57 creatinine levels 57 macrolide antibiotic 57 splenectomized 57 HGPIN 57 Rev Dex 57 cerebrovascular events 57 folinic acid 57 antibiotic prophylaxis 57 attain statistical significance 57 adalimumab Humira 57 fetuin 57 UKPDS 57 KRAS mutant tumors 57 oral FTY# 57 hypofractionated radiation 57 tHcy concentrations 57 recurrent ischemia 57 abdominal adiposity 57 antiplatelet 57 mIU L 57 stable angina 57 pyridostigmine 57 thyrotropin levels 57 ULORIC 57 #.#mg/dL 57 MACCE 57 fasting plasma glucose FPG 57 colorectal neoplasms 57 verapamil 57 hip BMD 57 renoprotective 57 renal toxicity 57 thiazides 57 cilostazol 57 STRIDE PD 57 prostate cancer CaP 57 angiographic restenosis 57 CHD CVD 57 antiviral efficacy 57 unfavorable cytogenetics 57 chronic LBP 57 canakinumab 57 serum homocysteine 57 initiating antiretroviral therapy 57 ICD implantation 57 UA NSTEMI 57 maximal tolerated 57 hypertensive patients 57 achieved ACR# 57 nonsevere 57 Fondaparinux 57 onset diabetes mellitus 57 ID TLR 57 labetalol 57 Meta analyzes 57 unstable angina UA 57 NEVO ™ 57 vitamin D inadequacy 57 d4T 57 non valvular atrial 57 postintervention 57 #mg/day [002] 57 atypical antipsychotic medications 57 sulphonylurea 56 lanthanum carbonate 56 adenoma detection 56 HER2 positive cancers 56 pentoxifylline 56 molecular weight heparins 56 parecoxib 56 KRAS mutations occur 56 platelet inhibitor 56 ritonavir boosted 56 lowering LDL cholesterol 56 severe renal impairment 56 coronary interventions 56 Perforomist Inhalation Solution 56 hemorrhagic complications 56 % CI #.#-#.# [008] 56 placebo controlled trials 56 clinically localized prostate 56 nonsignificant 56 ADHF 56 AZT zidovudine Retrovir 56 HER2 overexpression 56 ER CHOP 56 clopidogrel pretreatment 56 corticosteroid therapy 56 macrovascular events 56 lactate dehydrogenase LDH 56 subthreshold depression 56 leucopenia 56 CLL SLL 56 eplerenone 56 statin medications 56 serum folate concentrations 56 carotid artery stenting CAS 56 NHANES III 56 GnRH agonists 56 neuropsychological impairment 56 chlamydial infection 56 levosimendan 56 prescribed statins 56 BEACOPP 56 candidemia 56 lispro 56 #mg dose [001] 56 serum cholesterol 56 lenalidomide dexamethasone 56 bilirubin levels 56 prescribe statins 56 thrombotic events 56 phytoestrogen intake 56 rFVIIa 56 ruptured aneurysms 56 paroxetine Paxil 56 gemcitabine Gemzar 56 SCIg 56 HAART regimens 56 pulmonary exacerbation 56 BEXXAR Therapeutic Regimen 56 analgesic efficacy 56 Fasting blood glucose 56 azacitidine 56 systemic hypotension 56 estrogen progestin therapy 56 DHA supplementation 56 urolithiasis 56 EoE 56 diuretic chlorthalidone 56 serum phosphorus 56 TAXUS Stent 56 systemic corticosteroid 56 cytoreductive nephrectomy 56 glycoprotein IIb IIIa inhibitors 56 drug eluting stent implantation 56 hypercholesterolemic patients 56 aminotransferase levels 56 spontaneous preterm delivery 56 Helicobacter pylori eradication 56 serum selenium 56 TAXUS VI 56 apremilast 56 hepatorenal syndrome 56 ExTRACT TIMI 56 anti HBs 56 chlorambucil 56 interindividual variability 56 dapagliflozin plus 56 MS relapses 56 Taxus Stent 56 adenotonsillectomy 56 statins 56 cardiovascular mortality 56 anticoagulant warfarin 56 tecarfarin 56 GI bleeding 56 Complication rates 56 thrombolytic therapy 56 EXJADE 56 basal bolus regimen 56 metastatic lung cancer 56 oral allopurinol 56 neurologic complications 56 vildagliptin 56 CHD mortality 56 LDL C 56 favorable pharmacokinetic profile 56 antiplatelet therapy 56 angiotensin II receptor blockers 56 thrombolytic agents 56 oral antidiabetic medication 56 ejection fractions 56 coronary artery bypass grafts 56 μmol L 56 Bivalirudin 56 PHPT 56 deep venous thromboses 56 Avandia Actos 56 antithrombotics 56 DAPT 56 estramustine 56 LDL cholesterol concentrations 56 interpersonal psychotherapy 56 weight heparin LMWH 56 percutaneous vertebroplasty 56 tertiles 56 postprocedure 56 ICD implants 56 Ticlid 56 interferon therapy 56 serum potassium 56 Eligen R B# 56 leukocyte count 56 prognostic indicators 56 statins cholesterol lowering 56 sulfasalazine 56 virologic suppression 56 NIASPAN 56 hyperphenylalaninemia HPA due 56 probiotic supplementation 56 EpCAM expression 56 lowering homocysteine 56 nonfatal MI 56 receiving highly emetogenic 56 Operative mortality 56 tamoxifen Nolvadex ® 56 fragility fracture 56 noninferiority 56 TAXUS Express Stent 56 PREZISTA rtv 56 urinary cortisol 56 heavily pretreated 56 mitochondrial toxicity 56 Symptom severity 56 glycemic diets 56 Fasting glucose 56 metformin sulfonylurea 56 virological suppression 56 cerebral microbleeds 56 completely resected 56 androgen deprivation 56 VTE prophylaxis 56 penetrance 56 PNH patients 56 histologically confirmed 56 resected pancreatic cancer 56 AEGR 56 INCB# [003] 56 coronary revascularization 56 venous thromboembolic disease 56 MoxDuo TM IR 56 Renal dysfunction 56 primary hypercholesterolemia 56 onset atrial fibrillation 56 subcutaneous insulin 56 BARACLUDE ® 56 carotid stenting 56 Skin sterol 56 revascularization procedure 56 sustained virologic response 56 plasma pharmacokinetics 56 dietary folate 56 nephrolithiasis 56 liposomal amphotericin B 56 HIV uninfected 56 KRAS status 56 virologic response 56 systemic embolism 56 MADRS score 56 conventional DMARDs 56 hypoglycemic episodes 56 nonselective NSAIDs 56 Insulin sensitivity 56 morbidity mortality 56 NSTEMI 56 conjugated equine estrogen 56 tapentadol ER 56 atherothrombotic disease 56 candesartan cilexetil 56 lipid levels 56 URTI 56 elevated creatinine 56 statistically significant p = 56 Hypotension 56 INVEGA ® 56 TT genotype 56 multivariable analysis 56 CYP#D# inhibitors 56 LEXIVA r 56 ezetimibe simvastatin 56 BRCA2 mutation carriers 56 prospectively randomized 56 mm Stent 56 oral clodronate 56 pegylated interferon alfa 2b 56 cardiac troponin T 56 nonsignificant trend 56 Adjunctive 56 symptomatic intracranial hemorrhage 56 % Confidence Interval 56 Zevalin consolidation 56 eculizumab therapy 56 PCA3 scores 56 Events MACE 56 protease inhibitor PI 56 neurocognitive outcomes 56 serum parathyroid hormone 56 serum ferritin 56 spirometric 56 asymptomatic PAD 56 deferasirox 56 inhaled corticosteroid therapy 56 thrombogenic 56 postoperative radiotherapy 56 timepoints 56 carbohydrate diets 56 coronary blockages 56 overt nephropathy 56 nondepressed 56 containing abacavir 56 diastolic blood pressures 56 tiotropium 56 plasma cortisol 56 gastrointestinal GI bleeding 56 OGTT 56 highest tertile 56 Platelet counts 56 histologic subtype 56 inhaled iloprost 56 mEq L 56 oral anticoagulant therapy 56 hyperkalemia 56 decompensated heart failure 56 prophylactic cranial irradiation 56 systolic blood pressures 56 fluvoxamine Luvox 56 Anticoagulants 56 Randomized controlled 56 isolated systolic hypertension 56 abnormal lipid 56 octreotide LAR 56 atheroma volume 56 myocardial infarctions 56 biochemical relapse 56 daily subcutaneous injections 56 Hyperlipidemia 56 intravenous cyclophosphamide 56 antibiotic regimens 56 glycemic index diets 56 medication nonadherence 56 primary aldosteronism 56 ACTEMRA TM 56 topical NSAIDs 56 carotid artery blockage 56 Prehypertension 56 lipid abnormalities 56 gp# vaccine 56 antigen PSA levels 56 serum testosterone 56 irbesartan 56 protein excretion 55 SLNB 55 tigecycline 55 NovoTTF 55 restenosis reblockage 55 FDG uptake 55 subclinical hyperthyroidism 55 mammographic density 55 antihypertensive medication 55 RBC transfusions 55 calcium antagonists 55 Univariate analysis 55 acromegalic patients 55 T2DM 55 pulmonary toxicity 55 Abciximab 55 catheter angiography 55 tipranavir ritonavir 55 ACE Inhibitor 55 glargine 55 SHBG levels 55 argatroban 55 anemia neutropenia 55 SYNTAX trial 55 invasive aspergillosis 55 reactogenicity 55 antioxidant vitamin supplements 55 nonfasting 55 mmHg diastolic 55 metabolic parameters 55 pharmacokinetic characteristics 55 plasma renin 55 corticosteroid dose 55 Hb A1c 55 dacarbazine chemotherapy 55 endocrine therapies 55 virologic failure 55 coronary revascularization procedures 55 antidepressant efficacy 55 dose corticosteroids 55 Molecular Weight Heparin 55 obese postmenopausal 55 RCTs 55 serum IgE 55 pegylated interferon alfa 55 follicular lymphomas 55 HAM D# scores 55 TNF alpha antagonist 55 micafungin 55 atypical ductal hyperplasia 55 serum aminotransferase levels 55 statin cholesterol lowering 55 RBP4 levels 55 malabsorptive 55 mild renal insufficiency 55 renal artery stenosis 55 ARCALYST ® 55 subtrochanteric 55 QVAR R 55 otamixaban 55 antiarrhythmic 55 ventricular tachyarrhythmia 55 serum magnesium 55 TPV r 55 plasma folate 55 adjunctive placebo 55 cTnI 55 gemcitabine cisplatin 55 CCyR 55 randomized controlled trials 55 left ventricular dysfunction 55 serum testosterone levels 55 mean serum phosphorus 55 non aspirin NSAIDs 55 psychiatric comorbidity 55 Orthostatic hypotension 55 atazanavir ritonavir 55 colorectal cancer incidence 55 dose regimens 55 GH deficiency 55 CK MB 55 antithrombotic agents 55 inecalcitol 55 hydroxychloroquine 55 mixed hyperlipidemia 55 urinary oxalate 55 weekly subcutaneous injections 55 cystatin C 55 ALT flares 55 mcg albinterferon alfa 2b 55 mg hydrochlorothiazide